Safety and efficacy of stroke thrombolysis at a secondary provincial hospital in New Zealand

New Zealand Medical Journal

Volumn 125, Issue 1358, 2012, Pages 35-43

  Ranta, Annemarei ^a   Chan, Calvin ^a   Rump, Dorothea ^a   Cariga, Pietro ^a  

^a MidCentral Health ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; AMBULANCE; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEW ZEALAND; PATIENT TRANSPORT; RANKIN SCALE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HOSPITALS, RURAL; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDIES; SAFETY; STROKE; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84864964943     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. NINDS. Tissue Plasminogen Activator for Acute Ischemic Stroke. New England Journal of Medicine 1995;333:1581-8.
2. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003:CD000213.
3. Graham GD. Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data. Stroke 2003;34:2847-50.
4. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
5. Fink J. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment. N Z Med J 2005;118:U1430.
6. Szoeke CE, Parsons MW, Butcher KS, et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust 2003;178:324-8.
7. Leyden JM, Chong WK, Kleinig T, Lee A, Field JB, Jannes J. A population-based study of thrombolysis for acute stroke in South Australia. Med J Aust 2011;194:111-5.
8. Hsu YC, Sung SF, Ong CT, Wu CS, Su YH. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital. Acta Neurol Taiwan 2009;18:14-20.
9. Gebhardt JG, Norris TE. Acute stroke care at rural hospitals in Idaho: challenges in expediting stroke care. J Rural Health 2006;22:88-91.
10. Barroso B, Morisset C, Larrieu JM, et al. Stroke thrombolysis in the emergency department as an alternative service for community hospitals lacking a stroke unit. Eur J Emerg Med 2008;15:71-4.
11. Weintraub MI. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke; a journal of cerebral circulation 2006;37:1917-22.
12. Ong CT, Su YH, Sung SF, Wu CS, Hsu YC. Ethic issue in ischemic stroke patients wit thrombolytic therapy. Acta Neurol Taiwan 2009;18:296-300.
13. Hess DC, Switzer JA. Stroke telepresence. Neurology 2011;76:1121-3.
14. Vaishnav AG, Pettigrew LC, Ryan S. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals. Clin Neurol Neurosurg 2008;110:451-4.